Mr. Daniel M Mahoney

Practice Details

• Firm Information
  Position

  Partner

  Firm Name

  Snell & Wilmer L.L.P.
• Representative Cases & Transactions
  Transactions

  Representative Transactions: Mergers & Acquisitions: Special Counsel to publicly held medical device company in its $3.5 billion sale to a public, multinational drug company; Represented publicly held manufacturer of CMP Machines in its $250 million merger with large public company; Represented private medical diagnostic company in its $185 million merger with large public company; Represented public company in its $40 million acquisition of a private biotechnology company; Represented public company in connection with defense of hostile takeover attempt; Represented public manufacturer of satellite communication systems in hostile takeover attempt of another public company; Represented group of controlling shareholders in takeover of public company; Represented private equity fund in its $40 million acquisition of manufacturing company; Represented manufacturer of large-scale test equipment in its $40 million sale to a private equity fund; Represented manufacturer of manufactured log homes in its sale to a private equity fund; Represented public online classified/yellow pages company in its $12 million stock-for-stock acquisition of a private online classified company; Represented nationally recognized franchisor of ice cream stores in a joint venture; Represented a private manufacturer of small wind turbines in a Chinese joint venture with a Chinese company; Represented public home builder in its acquisition of private home builder; Represented semiconductor company in its sale to large public company; Represented private company in the sale of its semiconductor fab facility and selected assets to a Japanese corporation; Venture Capital Transactions: Represented semiconductor chip company in multiple rounds of venture capital financing totaling over $100 million in venture financing; Represented online knowledge management company in $24 million Series C Preferred Stock financing; Represented online physician portal in multiple rounds of venture capital financing totaling over $60 million in venture financing; Represented medical device reprocessing company in multiple rounds of venture capital financing totaling over $38 million in financing; Represented manufacturer of small wind turbines in multiple round of venture capital financing; Represented medical device company in its $7.5 million Series B Preferred Stock financing; Represented drug development company in multiple rounds of Series A and Series B private equity investment; Represented a drug development company in its license of technology from the Translational Genomic Research Institute (TGen) and Series A Preferred Stock financing by Silicon Valley venture capital fund; Represented a company with an online information and collaboration portal for physicians in its license of technology from TGen and private equity investment; Represented Palo Alto venture capital fund in its lead investment in a $4 million Series A Preferred Stock financing of software company; Represented venture capital fund in its Series A Preferred Stock financing of Atlanta-based software company; Represented German venture capital fund in its $3 million Series A Preferred Stock financing of a Denver-based life sciences company; Represented venture capital fund in its $8 million Series C Preferred Stock financing of Denver-based software company; Represented Sacramento-based venture capital fund in its investment in an information technology company; Represented venture capital fund in its investment as lead investor in a medical diagnostics company; Represented venture capital fund in its investment as lead investor in a semiconductor company; Represented Internet company in its recapitalization and placement of Preferred Stock and debt financing to Silicon Valley venture capital investors; Fund Formations: Represented Phoenix-based life science fund in the formation and raising of a $20 million fund; Represented Phoenix-based private equity fund in the formation and raising of a $120 million fund; Represented and advised numerous private equity sponsors in the formation and raising of opportunity funds, venture funds and private equity funds from private investors that focus on the investment in or acquisition of identified operating businesses, real estate, and distressed loans or assets; Securities Offerings & Related Transactions: Represented numerous public companies in 'PIPE' transactions; Represented companies seeking to take their companies public; Represented public companies in the adoption or termination 'poison pills' and related anti-takeover measures, stock repurchase programs and tender offers as well as public equity and debt financing